This comprehensive course is designed to provide an in-depth exploration of key concepts in pharmacology

April 2022 Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization --Design Pharmaceuticals, a company redesigning small molecule drug discovery, today announced the closing Design Pharmaceuticals’ platform is based on ultrahigh-throughput technologies that biomine drug-like

April 2022 "SAN DIEGO, April 12, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization

December 2021 Crinetics Pharmaceuticals announced the formation of an independently operated new company and Crinetics to Collaborate on Multiple Additional targets SAN DIEGO, October 18, 2021 — Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization

Ecosystem Partners We are grateful to Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals

Ecosystem Partners We are grateful to Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals

Ecosystem Partners We thank Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals , Montana